Adamis Pharmaceuticals Corporation

CA · United States · Reporting entity ID 100000971836

Total reported 2019–2025

$2.08M

#1,017 of 2,960 reporting companies — 0% of all reported industry payments

$0 in general payments across 0 records, plus $2.08M in research funding across 511 records.

How it breaks down

Research funding $2,081,805

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.